Intuitive Surgical, Inc. (ISRG)

Healthcare
Medical Instruments & Supplies
United States
Yahoo Finance  •  Trading View  •  Company site
Price
$435.61
▼ -0.78 (-0.18%)
Market Cap
$156,155,953,152
Shares: 355,200,000
P/E
79.82
P/B: 11.28
ROE
14.13%
Current Ratio: 4.07
Fundamentals Score
59 (NEUTRAL)

Company Overview

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Headquarters: 1020 Kifer Road, Sunnyvale, CA, 94086-5304, United States  |  Employees: 15638  |  Website: intuitive.com
Key Contacts
IR / Phone: 408 523 2100
Exchange: NMS
Industry: Medical Instruments & Supplies
Quick Financial Snapshot
Revenue$8,352,100,000
Net Income$2,322,600,000
Free Cash Flow$1,303,800,000
Book Value / Share$46.54

Balance Sheet & Liquidity

Total Liabilities$2,309,000,000
Total Equity$16,433,700,000
Debt / Equity0.01
Current Ratio4.07
Interest CoverageN/A
Working Capital$5,365,700,000

Valuation Metrics

Core multiples and valuation signals — useful to compare vs peers.

P/E (TTM)79.82
Industry P/EN/A
Forward P/E55.42
P/B11.28
Price / Sales22.20
P / FCF142.20
EV / EBITDA65.29
Graham Number$82.50
DCF (placeholder)
Notes: red items typically indicate expensive multiples relative to fundamentals. Use the "Compare with industry" tool for context.

EPS (Annual)

Financial Performance

Revenue vs Net Income

Free Cash Flow (annual)

Profitability & Efficiency

Gross Margin 67.46%
Operating Margin 28.12%
Net Margin 27.81%
ROIC 11.99%
Asset Turnover 0.44

Automated Fundamental Signals (Score: 59)

Passed
  • EPS shows upward trend
  • EPS CAGR 21.31%
  • Price CAGR 21.78%
  • ROIC 12.0%
  • Gross Margin 67.5%
  • Debt/Equity ratio
  • Operating Margin 28.1%
  • Positive Free Cash Flow
  • Current Ratio
  • Return on Tangible Assets
  • Low reliance on intangibles
Failed
  • P/FCF 142.20
  • P/B Ratio 11.28
  • CapEx intensity
  • Interest Coverage
  • Debt/EBITDA
  • Price below Graham Number
  • DCF valuation (Overvalued)

Price Chart (Candlestick)

Technical Analysis (Score: 60)

RSI (14)43.00
SMA 50456.16
SMA 200513.74
MACD-5.50
Signal NEUTRAL
RSI 43.0, SMA trend bearish, momentum -10.7%.

Governance & Management

Governance scores: Audit: 1 | Board: 6 | Compensation: 5 | Shareholder Rights: 4
Executive Team
NameTitle
Dr. Gary S. Guthart Ph.D. Executive Chair (1966)
Mr. David J. Rosa CEO & Director (1968)
Mr. Jamie E. Samath CFO, Head of Business Technology & Enterprise Technology Leader (1971)
Mr. Henry L. Charlton Executive VP and Chief Commercial & Marketing Officer (1970)
Dr. Brian E. Miller Ph.D. Chief Digital Officer (1975)
Mr. Fredrik Widman VP, Principal Accounting Officer & Corporate Controller (—)
Mr. Milind Wagle Chief Information Officer (—)
Mr. Gary H. Loeb J.D. Chief Legal & Compliance Officer (1970)
Governance data last updated: 10/1/2025

Latest News

No news available for this company.

← Back